At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $1.63B, above the global median of $1.14B
- FinancialsAltman Z-Score 1.96: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.09%Above 5Y avg (1.44%)
Annual Rate
CNY 0.30Paid annual
Payout Ratio
86.0%High
Payback Period
47.9 yr
Last Ex-Dividend
Sep 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.86BCNY1.63B · vs all stocks (USD)
Trailing P/E
25.11xvs Pharmaceutical Retailers peers
Revenue (TTM)
22.46BCNY3.37B · vs all stocks (USD)
Profit Margin
1.92%vs Pharmaceutical Retailers peers
Beta
0.4210xvs all stocks
52-Week Change
-14.11%vs all stocks
Market Capitalization
10.86BCNY1.63B · vs all stocks (USD)
Enterprise Value
13.06BCNY1.96B · vs all stocks (USD)
Trailing P/E
25.11xvs Pharmaceutical Retailers peers
Forward P/E
11.91xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
0.4835xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
1.56xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.5820xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
10.19xvs Pharmaceutical Retailers peers
Gross Margin
31.40%vs Pharmaceutical Retailers peers
Profit Margin
1.92%vs Pharmaceutical Retailers peers
Operating Margin
5.80%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
3.68%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
8.00%vs Pharmaceutical Retailers peers
Revenue (TTM)
22.46BCNY3.37B · vs all stocks (USD)
Revenue per Share (TTM)
29.56CNYUpdated Oct 23, 2026Quarterly Revenue Growth
3.30%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
7.18BCNY1.08B · vs all stocks (USD)
EBITDA (TTM)
1.32BCNY197.87M · vs all stocks (USD)
Net Income (TTM)
430.77MCNY64.61M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
24.20%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
2.92BCNY438.03M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.96BCNY294.07M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3000CNYUpdated Oct 23, 2026Trailing Annual Dividend Yield
2.09%vs all stocks
5-Year Average Dividend Yield
1.44%vs all stocks
Payout Ratio
85.96%vs Pharmaceutical Retailers peers
Minority Interest (Equity)
460.70MCNYFY2025 · Dec 31, 2025Revenue
22.24BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
15.05BCNYFY2025 · Dec 31, 2025Gross Profit
7.18BCNYFY2025 · Dec 31, 2025Operating Income
1.14BCNY171.70M · vs all stocks (USD)
Pre-tax Income
756.17MCNYFY2025 · Dec 31, 2025Income Tax Expense
215.72MCNYFY2025 · Dec 31, 2025Net Income
540.45MCNYFY2025 · Dec 31, 2025EBIT
886.44MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.60BCNYFY2025 · Dec 31, 2025Research & Development
51.07MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
2.08BCNYFY2025 · Dec 31, 2025Other Operating Expenses
152.69MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
13.37MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
130.27MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.5000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.5000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
763.69MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
763.69MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
540.45MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-158.60MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
1.21BCNYFY2025 · Dec 31, 2025Free Cash Flow
968.26MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.14BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
540.45MCNYFY2025 · Dec 31, 2025Other Non-cash Items
310.22MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
469.25MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-106.48MCNYFY2025 · Dec 31, 2025Capital Expenditures
-245.19MCNYFY2025 · Dec 31, 2025Net Acquisitions
-3.20MCNYFY2025 · Dec 31, 2025Purchase of Investments
-644.46KCNYFY2025 · Dec 31, 2025Sale of Investments
12.37MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-236.66MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.90BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.70BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-224.62MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.58BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.60BCNYFY2025 · Dec 31, 2025Shares Outstanding
758.89MSharesUpdated Oct 23, 2026Float Shares
379.21MSharesUpdated Oct 23, 2026% Held by Insiders
50.02%vs all stocks
% Held by Institutions
3.40%vs all stocks
Total Cash (MRQ)
2.33BCNY349.24M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.07CNYUpdated Oct 23, 2026Total Debt (MRQ)
3.94BCNY591.60M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5244xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
0.9020xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
9.20CNYUpdated Oct 23, 2026Total Assets
19.85BCNY2.98B · vs all stocks (USD)
Total Current Assets
8.83BCNYFY2025 · Dec 31, 2025Total Liabilities
12.85BCNYFY2025 · Dec 31, 2025Total Non-current Assets
11.01BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.69BCNYFY2025 · Dec 31, 2025Total Current Liabilities
10.16BCNYFY2025 · Dec 31, 2025Cash
1.12BCNYFY2025 · Dec 31, 2025Cash Equivalents
1.23BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.36BCNYFY2025 · Dec 31, 2025Accounts Receivable
2.11BCNYFY2025 · Dec 31, 2025Inventory
3.65BCNYFY2025 · Dec 31, 2025Accounts Payable
6.76BCNYFY2025 · Dec 31, 2025Short-term Debt
1.92BCNYFY2025 · Dec 31, 2025Other Current Liabilities
32.05MCNYFY2025 · Dec 31, 2025Long-term Debt
2.64BCNYFY2025 · Dec 31, 2025Common Stock (Book)
758.89MCNYFY2025 · Dec 31, 2025Retained Earnings
3.72BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
7.00BCNY1.05B · vs all stocks (USD)
52-Week Low
10.67CNYUpdated Oct 23, 202652-Week High
17.96CNYUpdated Oct 23, 202652-Week Change
-14.11%vs all stocks
Beta
0.4210xvs all stocks
50-Day MA
13.34CNYUpdated Oct 23, 2026200-Day MA
13.42CNYUpdated Oct 23, 2026Avg 10-Day Volume
19.66MSharesUpdated Oct 23, 2026Avg 30-Day Volume
13.24MSharesUpdated Oct 23, 2026Diluted EPS (TTM)
0.5700CNYUpdated Oct 23, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.96: grey zoneSignificant
Altman Z-Score: 1.96
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $1.63B, above the global median of $1.14BNotable
Market cap (USD): 1,628,740,697.164Global Median: 1,137,180,293.291
Revenue is $3.37B, above the global median of $566.17MNotable
Revenue (USD): 3,368,546,538.168Global Median: 566,172,992
Levered free cash flow is $294.07M, above the global median of $18.58MNotable
Levered free cash flow (USD): 294,070,014.236Global Median: 18,579,867.004
Companies that share the same coordination system — how they create, deliver, or capture value.
Sally Beauty Holdings Inc.
Tier 1FlowUnit ReplicationInterfaceSenseMaking
Ingles Markets Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Max Stock Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Migros Ticaret Anonim Sirketi
Tier 1FlowUnit ReplicationInterfaceProduction
BGF Retail Co. Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Dis-Chem Pharmacies Limited
Tier 1FlowUnit ReplicationInterfaceProduction
Redcare Pharmacy N.V.
Tier 1FlowUnit ReplicationInterfaceProduction
Trial Holdings Inc.
Tier 1FlowUnit ReplicationRiskInterface
Prosegur Compañía de Seguridad, S.A.
Tier 1FlowUnit ReplicationRuleProduction
Com7 Public Company Limited
Tier 1FlowUnit ReplicationInterfaceAttention